Abstract:Objective: To investigate the relationship between different delivery timing and the outcome of premature rupture of membranes (PROM) in primiparous women. Methods: Within the context of exploring optimal delivery strategies for managing PROM, we conducted a retrospective study at Shijiazhuang Fourth Hospital. From May 2019 to May 2022, a total of 400 single pregnant women with premature rupture of membranes (PROM) at different gestational weeks (28-36 weeks) were enrolled. This study aims to understand the impact of delivery timing on pregnancy outcomes more clearly. Pregnant women were divided into two distinct groups based on gestational weeks: Group A (28 to 33 weeks, n=192) and Group B (34 to 36 weeks, n=208). The clinical data of pregnant women were analyzed retrospectively, and the methods of delivery, maternal and infant pregnancy outcomes, and factors affecting delivery outcomes were compared in different groups. Results: Compared with the delivery methods of the two groups, the proportion of vaginal delivery in group A (69.27%) was significantly higher than that in group B (49.04%). The proportion of assisted vaginal delivery and cesarean section (13.54% and 17.19%) was significantly lower than that in group B (18.75% and 32.21%) (P < .001). There was no difference in neonatal death outcomes between the two groups (P > .297). The incidence of chorioamnionitis, postpartum hemorrhage, and puerperal infection in group A (25.00%), (19.27%) and (11.46%) was significantly higher than that in group B (6.25%), (5.29%) and (2.40%), respectively. The incidence rates of neonatal asphyxia, neonatal respiratory distress syndrome (NRDS), and hypoxic-ischemic encephalopathy (HIE) in group A were 9.38%, 7.29%, and 6.77%, which were significantly higher than those in group B (1.92%, 0.48% and 0.48%) (P = .001). There was no difference in neonatal death outcomes at different delivery times (P = .259). The incidence rates of amniotic infection, postpartum hemorrhage, and puerperal infection were (3.98%), (7.39%) and (3.41%), which were significantly lower than those of pregnant women from PROM to delivery time ≥48 h (24.11%), (15.63%) and (9.38%). The incidence rates of neonatal asphyxia, NRDS, and HIE were (1.14%), (1.14%) and (2.27%) in neonates from PROM to delivery time < 48 h, significantly lower than those in neonates from PROM to delivery time ≥48 h (8.93%), (5.80%), and (4.46%) (P < .001). Logistic regression analysis showed that the older the gestational week was the protective factor for amniotic space infection, postpartum hemorrhage, puerperal infection, neonatal asphyxia, NRDS, and HIE. Late delivery time was an independent risk factor for amniotic cavity infection(P < .001), postpartum hemorrhage(P = .014), puerperal infection(P = .023), neonatal asphyxia(P = .004), and NRDS (P = .028). Conclusion: In pregnant women with PROM who are not at full term, a greater gestational week is associated with a lower rate of adverse delivery outcomes. In contrast, a longer time interval between membrane rupture and delivery is associated with a higher rate of adverse delivery outcomes.

Role of Matrix Metalloproteinase-2,9 and Their Inhibitors in Premature Rupture of Membranes

Expressions of matrix metalloproteinases and their tissue inhibitors in premature rupture of the fetal membranes

Expression of Matrix Metalloproteinase-2, -9, and -14, Tissue Inhibitors of Metalloproteinase-1, and Matrix Proteins in Human Placenta During the First Trimester1

Expression levels and significance of macrophage migration inhibition factor and matrix metalloproteinase-9 in fetal membranes of pregnant women with premature rupture of fetal membranes

Role of Caspase-3,Caspase-8 and Caspase-9 in Premature Rupture of Fetal Membranes

Expression of the Transcription Factor Ets-1 and Matrix Metalloproteinases-9 in the Premature Ruptured Membranes

Effects of Matrix Proteins on the Expression of Matrix Metalloproteinase-2, -9, and -14 and Tissue Inhibitors of Metalloproteinases in Human Cytotrophoblast Cells During the First Trimester1

Study on the Relationship Between the Expression of Matrix Metalloproteinase-9 and Premature Rupture of Membrane As Pregnant Women with Periodontal Inflammation

Expression and Role of Tumor Necrosis Factor Receptor-1, 2 in Fetal Membranes of Premature Rupture of Membranes

Genetic and Epigenetic Mechanisms Combine to Control MMP1 Expression and Its Association with Preterm Premature Rupture of Membranes.

Upregulation of TNF-α and IL-6 Induces Preterm Premature Rupture of Membranes by Activation of ADAMTS-9 in Embryonic Membrane Cells

The preterm cervix reveals a transcriptomic signature in the presence of premature prelabor rupture of membranes

Drastic Induction of MMP-7 by Cortisol in the Human Amnion: Implications for Membrane Rupture at Parturition

Characterization of Inflammation/Immune-, Acute Phase-, Extracellular Matrix-, Adhesion-, and Serine Protease-Related Proteins in the Amniotic Fluid of Women With Early Preterm Prelabor Rupture of Membranes

Role of Bcl-2 Expression in Premature Rupture of Membrane

Inflammation-related downregulation of zonula Occludens-1 in fetal membrane contributes to development of prelabor rupture of membranes

Progestins Inhibit Interleukin-1β-Induced Matrix Metalloproteinase 1 and Interleukin 8 Expression via the Glucocorticoid Receptor in Primary Human Amnion Mesenchymal Cells

The Relationship between Different Delivery Timing and the Outcome of Premature Rupture of Membranes in Primiparous Women

Polymorphisms in the MTHRF, VDR, MMP-9 and IL-β genes and the risk of premature rupture of membranes.

Frontiers in the Etiology and Treatment of Preterm Premature Rupture of Membrane: from Molecular Mechanisms to Innovative Therapeutic Strategies.

The Preventive Effect on Premature Rupture of Membrane by Treating Vulvovaginal Candidiasis During Pregnancy